![Mikhail Sergeevich Nekrasov](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Mikhail Sergeevich Nekrasov currently works at NANOLEK LLC, as Chief Executive Officer and Makiz-Pharma ZAO, as Chairman.
Cargos activos de Mikhail Sergeevich Nekrasov
Empresas | Cargo | Inicio |
---|---|---|
Makiz-Pharma ZAO
![]() Makiz-Pharma ZAO Pharmaceuticals: MajorHealth Technology Makiz-Pharma ZAO manufactures pharmaceutical products. Its main products are medicines for cardiovascular problems and gastroenterology. The company was founded in 2001 and is headquartered in Moscow, Russia. | Presidente | - |
Nanolek LLC
![]() Nanolek LLC Pharmaceuticals: MajorHealth Technology Nanolek LLC provides biotechnological services. Its project provides integrated pharmaceutical production facilities with the usage of a new technology platform that allows receiving innovative vaccines and pharmaceuticals based on nanotechnology and nanomaterials. The firm's products include Nanovaccines and other biomedical products, Organogel-based ointments and gels, and Solid dosage forms. The company was Founded on April 28, 2011 and is headquartered in Moscow, Russian Federation. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Makiz-Pharma ZAO
![]() Makiz-Pharma ZAO Pharmaceuticals: MajorHealth Technology Makiz-Pharma ZAO manufactures pharmaceutical products. Its main products are medicines for cardiovascular problems and gastroenterology. The company was founded in 2001 and is headquartered in Moscow, Russia. | Health Technology |
Nanolek LLC
![]() Nanolek LLC Pharmaceuticals: MajorHealth Technology Nanolek LLC provides biotechnological services. Its project provides integrated pharmaceutical production facilities with the usage of a new technology platform that allows receiving innovative vaccines and pharmaceuticals based on nanotechnology and nanomaterials. The firm's products include Nanovaccines and other biomedical products, Organogel-based ointments and gels, and Solid dosage forms. The company was Founded on April 28, 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
- Bolsa de valores
- Insiders
- Mikhail Sergeevich Nekrasov